Terms: = Skin cancer AND BTG1, P62324, 694, ENSG00000133639 AND Prognosis
9 results:
1. An immune risk score with potential implications in prognosis and immunotherapy of metastatic melanoma.
Sheng Y; Tong L; Geyu L
Int Immunopharmacol; 2020 Nov; 88():106921. PubMed ID: 32871477
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of low expression of B-cell translocation gene 1 (
Li G; Yue Y; Li W; Chen Y; Fan H; Yuan J; Chen Z; Liu J
J Biosci; 2020; 45():. PubMed ID: 32457282
[TBL] [Abstract] [Full Text] [Related]
3. Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.
Hope-Stone L; Brown SL; Heimann H; Damato B
Eye (Lond); 2019 Sep; 33(9):1478-1484. PubMed ID: 30988421
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.
Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB
Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617
[TBL] [Abstract] [Full Text] [Related]
5. Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France.
Hurtaud A; Donnadieu A; Escalup L; Cottu PH; Baffert S
Breast; 2016 Dec; 30():73-79. PubMed ID: 27639032
[TBL] [Abstract] [Full Text] [Related]
6. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study.
Abali H; Celik I; Karaca B; Turna H; Kaytan Saglam E; Akman T; Oztop I; Senol Coskun H; Serdar Turhal N; Sezer A; Nayir E; Arican A; Ozkan M; Sevinc A; Demir G; Budakoglu B; Issikdogan A; Engin H; Kilickap S; Coskun U; Oyan B; Harputluoglu H; Er O; Kavgaci H; Elk Ran T
J BUON; 2015; 20(4):1137-41. PubMed ID: 26416068
[TBL] [Abstract] [Full Text] [Related]
7. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
[TBL] [Abstract] [Full Text] [Related]
8. [prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of the histological features of malignant melanoma.
McGovern VJ; Shaw HM; Milton GW; Farago GA
Histopathology; 1979 Sep; 3(5):385-93. PubMed ID: 488922
[TBL] [Abstract] [Full Text] [Related]
